| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.12 | 5e-05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |